Trump’s drug price ultimatum sets pharma firms scrambling

A variety of generic pills and capsules.  Nenov | Moment | Getty Images Pharmaceutical firms are scrambling to respond to a fresh ultimatum from U.S. President Donald Trump demanding “binding commitments” to lower their drug prices stateside. The White House said Thursday that President Trump had sent letters to 17 major pharmaceutical firms outlining the…

Read More

Moderna (MRNA) Q2 2025 earnings

Moderna logo is seen in Warsaw, Poland on April 9, 2025. Jakub Porzycki | Nurphoto | Getty Images Moderna on Friday lowered the high end of its 2025 revenue outlook due to a delay in vaccine shipments to the U.K., but beat Wall Street’s expectations for the second quarter as it works to cut costs….

Read More

CVS Health (CVS) earnings report Q2 2025

The CVS pharmacy logo is seen outside of a storefront on August 07, 2024 in Austin, Texas.  Brandon Bell | Getty Images CVS Health on Thursday reported second-quarter earnings and revenue that topped estimates and raised its adjusted profit outlook, as it sees strength in its retail pharmacy business and some improvement in its insurance…

Read More

Merck (MRK) earnings report Q2 2025

Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches…

Read More

Firms urge for clarity under EU-U.S. trade deal

Shelf of pharmaceutical products. D3sign | Moment | Getty Images Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive sector-specific levies could risk blowing up the entire deal. Ambiguity abounds around the terms for pharmaceutical goods under the trade truce agreed Sunday, which imposes…

Read More